| Dr Ria Dirghayu Desai, MD | |
|
259 E Erie St Ste 1520, Chicago, IL 60611-3111 | |
| (312) 695-8150 | |
| Not Available |
| Full Name | Dr Ria Dirghayu Desai |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 11 Years |
| Location | 259 E Erie St Ste 1520, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235572173 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | 036.142549 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwestern Medical Faculty Foundation | 4587576814 | 3255 |
News Archive
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection?
A postdoctoral fellow in the UT Dallas Callier Center for Communication Disorders has won a competitive research grant to study the effectiveness of bilingual education programs.
ARIAD Pharmaceuticals, Inc. today announced results of preclinical studies on its investigational anaplastic lymphoma kinase (ALK) inhibitor - AP26113 - showing potent inhibition of the target protein and of mutant forms that are resistant to the first-generation ALK inhibitor, which currently is in clinical trials in patients with cancer. ARIAD scientists presented these data today at the annual meeting of the American Association for Cancer Research (AACR) in Washington, D.C.
Prism Medical Ltd. today announced its results for the fiscal year ended November 30, 2010. Revenues in fiscal 2010 were $66.6 million compared to $65.7 million in fiscal 2009.
Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.
› Verified 8 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection?
A postdoctoral fellow in the UT Dallas Callier Center for Communication Disorders has won a competitive research grant to study the effectiveness of bilingual education programs.
ARIAD Pharmaceuticals, Inc. today announced results of preclinical studies on its investigational anaplastic lymphoma kinase (ALK) inhibitor - AP26113 - showing potent inhibition of the target protein and of mutant forms that are resistant to the first-generation ALK inhibitor, which currently is in clinical trials in patients with cancer. ARIAD scientists presented these data today at the annual meeting of the American Association for Cancer Research (AACR) in Washington, D.C.
Prism Medical Ltd. today announced its results for the fiscal year ended November 30, 2010. Revenues in fiscal 2010 were $66.6 million compared to $65.7 million in fiscal 2009.
Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ria Dirghayu Desai, MD 555 W Kinzie St Apt 2406, Chicago, IL 60654-5855 Ph: (757) 620-6812 | Dr Ria Dirghayu Desai, MD 259 E Erie St Ste 1520, Chicago, IL 60611-3111 Ph: (312) 695-8150 |
News Archive
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection?
A postdoctoral fellow in the UT Dallas Callier Center for Communication Disorders has won a competitive research grant to study the effectiveness of bilingual education programs.
ARIAD Pharmaceuticals, Inc. today announced results of preclinical studies on its investigational anaplastic lymphoma kinase (ALK) inhibitor - AP26113 - showing potent inhibition of the target protein and of mutant forms that are resistant to the first-generation ALK inhibitor, which currently is in clinical trials in patients with cancer. ARIAD scientists presented these data today at the annual meeting of the American Association for Cancer Research (AACR) in Washington, D.C.
Prism Medical Ltd. today announced its results for the fiscal year ended November 30, 2010. Revenues in fiscal 2010 were $66.6 million compared to $65.7 million in fiscal 2009.
Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.
› Verified 8 days ago
Paul Owen Phelps, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2001 N Halsted St Ste 200, Chicago, IL 60614 Phone: 312-888-5754 Fax: 833-989-2458 | |
Dr. David Alan Ramirez Jr., MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 225 E Chicago Ave # 70, Chicago, IL 60611 Phone: 312-227-6180 | |
Curtis James Heisel, Ophthalmology Medicare: Medicare Enrolled Practice Location: 251 E Huron St, Chicago, IL 60611 Phone: 312-227-4000 | |
Dr. John B Bello, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7447 W Talcott Ave, Suite 406, Chicago, IL 60631 Phone: 773-775-9755 Fax: 773-775-4306 | |
Adrienne Berman, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jhansi Raju, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3700 W 26th St, Chicago, IL 60623 Phone: 773-542-5203 Fax: 773-542-5841 | |
Catherine Jane Thomas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 1520, Chicago, IL 60611 Phone: 312-695-8150 Fax: 312-503-8152 |